PIROXICAM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for piroxicam and what is the scope of freedom to operate?
Piroxicam
is the generic ingredient in two branded drugs marketed by Pfizer, Breckenridge, Cycle, Egis, Flamingo Pharms, Hikma, Ivax Sub Teva Pharms, Micro Labs, Mylan, Norvium Bioscience, Nostrum Labs Inc, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem, Watson Labs, and Zydus Lifesciences, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.There are sixteen drug master file entries for piroxicam. Thirteen suppliers are listed for this compound.
Summary for PIROXICAM
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 19 |
| NDAs: | 23 |
| Drug Master File Entries: | 16 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 160 |
| Clinical Trials: | 28 |
| Patent Applications: | 8,043 |
| Drug Prices: | Drug price trends for PIROXICAM |
| Drug Sales Revenues: | Drug sales revenues for PIROXICAM |
| What excipients (inactive ingredients) are in PIROXICAM? | PIROXICAM excipients list |
| DailyMed Link: | PIROXICAM at DailyMed |
Recent Clinical Trials for PIROXICAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Monastir | Phase 2 |
| Mansoura University | Phase 2 |
| Farjad Zafar | Phase 4 |
Pharmacology for PIROXICAM
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for PIROXICAM
Anatomical Therapeutic Chemical (ATC) Classes for PIROXICAM
US Patents and Regulatory Information for PIROXICAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Sub Teva Pharms | PIROXICAM | piroxicam | CAPSULE;ORAL | 074148-002 | Jun 3, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Micro Labs | PIROXICAM | piroxicam | CAPSULE;ORAL | 206152-002 | Dec 29, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | PIROXICAM | piroxicam | CAPSULE;ORAL | 073638-001 | Jan 28, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Unichem | PIROXICAM | piroxicam | CAPSULE;ORAL | 208340-001 | Apr 13, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Scs | PIROXICAM | piroxicam | CAPSULE;ORAL | 074036-001 | May 29, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PIROXICAM | piroxicam | CAPSULE;ORAL | 074460-001 | Sep 29, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Flamingo Pharms | PIROXICAM | piroxicam | CAPSULE;ORAL | 207938-001 | Sep 9, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PIROXICAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-002 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-003 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-002 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-003 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-003 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-002 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | FELDENE | piroxicam | CAPSULE;ORAL | 018147-003 | Apr 6, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
